The body’s immune system is supposed to attack invaders, not the liver itself. In autoimmune hepatitis, that wiring goes wrong, and white blood cells start chewing through hepatocytes the way they would a virus. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), it is a chronic disease in which the immune system attacks the liver and causes inflammation and damage. Left untreated, that inflammation can quietly progress to cirrhosis. Caught early and managed with the right prescriber-directed immunosuppression, most patients do well and can live a normal lifespan. This article is general education, not medical advice.
Estimates of how many Americans have the condition vary, and true prevalence is uncertain because many cases are diagnosed incidentally during a workup for elevated liver enzymes. Women account for a clear majority of cases. This guide walks through the two main subtypes, how doctors confirm a diagnosis, what treatment involves, and what life on long-term immunosuppression actually looks like – all as background for a conversation with a specialist, not a substitute for one.
What Autoimmune Hepatitis Is
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease driven by immune-mediated destruction of liver cells. Unlike viral hepatitis, no infection is involved. Unlike alcohol-related liver disease, drinking is not the trigger. The hallmark finding on liver biopsy is interface hepatitis, where lymphocytes pile up at the border between the portal tract and the liver lobule.
Hepatologists generally split AIH into two types. Type 1 accounts for the large majority of cases and shows up across all age groups, often alongside other autoimmune problems like Hashimoto’s thyroiditis or celiac disease. Type 2 is rarer, tends to strike children and young women, and often runs a more aggressive course. Both share the same general treatment approach, but type 2 patients frequently need lifelong therapy. For broader context on immune-mediated diseases, the Medical Conditions guide covers overlapping autoimmune categories.
Causes and Risk Factors
No single cause has been pinned down; experts are not sure exactly what causes AIH. Genetic susceptibility plays a role – certain HLA alleles (such as HLA-DR3 and HLA-DR4) raise risk, especially in people of European descent. Environmental triggers likely tip a genetically primed immune system over the edge. Suspected triggers include some viral infections and certain medications, such as nitrofurantoin and minocycline, according to the Mayo Clinic. Because drug-induced liver injury can mimic AIH, sorting out cause is part of the diagnostic work.
Patients with one autoimmune disease tend to collect others. AIH frequently overlaps with primary biliary cholangitis, primary sclerosing cholangitis, type 1 diabetes, vitiligo, thyroid disease, and ulcerative colitis. Anyone diagnosed with a related autoimmune disorder – for example, those reading our ulcerative colitis material – should mention any persistent fatigue or right-upper-quadrant discomfort to their gastroenterologist rather than dismissing it.
Recognizing the Symptoms
Symptoms are often insidious, and a substantial share of patients have no symptoms at diagnosis – their disease is found because routine bloodwork shows elevated AST and ALT. Many others walk in with vague complaints: fatigue that does not lift with sleep, joint aches that wander, poor appetite, low-grade nausea, or mild itching. Some patients present in more obvious acute hepatitis – jaundice, dark urine, pale stools, and abdominal pain over the liver.
A small but important subset present in acute liver failure, with rapid yellowing, confusion (hepatic encephalopathy), and bleeding tendency. This is a medical emergency. Children with type 2 AIH are more likely to debut this way than adults with type 1.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience yellowing of the skin or eyes with confusion or excessive sleepiness, vomiting blood, black tarry stools, severe abdominal swelling, or easy bruising and bleeding alongside known liver disease.
How Doctors Diagnose It
There is no single confirmatory test; NIDDK notes that no one test can diagnose autoimmune hepatitis. Diagnosis draws on a scoring approach developed by liver specialists, weighing autoantibody titers, immunoglobulin (IgG) levels, exclusion of viral hepatitis, and biopsy findings. Most workups start with a hepatitis panel to rule out hepatitis B and C, then move to autoantibodies: ANA and anti-smooth muscle antibody point toward type 1, and anti-LKM-1 toward type 2.
Serum IgG is typically elevated. A liver biopsy remains an important step – the reference standard for confirming interface hepatitis and staging fibrosis – and it can change management by revealing overlap syndromes or an alternative diagnosis such as drug-induced liver injury. Imaging and a careful history round out the picture. This diagnostic sequence is exactly why a liver specialist, rather than self-interpretation of lab results, should direct the workup.
Standard Treatment
The goal of treatment is biochemical remission: normalization of liver enzymes (AST, ALT) and IgG, with minimal inflammation on follow-up assessment. NIDDK describes treatment as medicines that suppress the immune system – most often corticosteroids and immunosuppressants. In practice, first-line therapy generally uses a corticosteroid (such as prednisone, or budesonide in selected non-cirrhotic patients), frequently combined with a steroid-sparing immunosuppressant such as azathioprine. Combining the two typically lets clinicians reduce the steroid faster and limit long-term steroid side effects.
Dosing is individualized and prescriber-directed. The specific medicines, starting doses, how quickly the steroid is reduced, and the maintenance plan are all set and adjusted by your specialist based on your labs, your response, and your other conditions – and are not something to copy from an article or manage on your own. Do not start, stop, or change these medicines without your prescriber, because both under-treatment (relapse and liver damage) and abrupt steroid discontinuation can be harmful. Most patients reach remission within roughly a year to a year and a half; those who cannot tolerate or do not respond to first-line therapy may be switched to other agents (such as mycophenolate mofetil, tacrolimus, or cyclosporine), often off-label, under specialist supervision. The American Association for the Study of Liver Diseases (AASLD) generally advises a sustained period of maintenance and documented normal labs before any attempt to taper off therapy – verify current guidance with your hepatologist.
Living With Long-Term Immunosuppression
Steroids carry their own bill: weight gain, mood changes, blood sugar elevation, bone loss, cataracts, and increased infection risk. Because of this, clinicians often pair longer-term steroid use with bone-protective measures such as calcium and vitamin D and periodic bone-density monitoring. Azathioprine warrants baseline testing (including TPMT enzyme status), since people with low TPMT activity can suffer serious bone-marrow suppression – another reason dosing must be individualized and monitored with regular bloodwork.
Live vaccines are generally avoided once on immunosuppressants, but inactivated vaccines (such as influenza, COVID-19, pneumococcal, and recombinant shingles) are typically encouraged – confirm timing with your care team. Patients are usually advised to avoid raw or undercooked animal products because of infection risk, and to avoid alcohol, which can accelerate liver damage. Once cirrhosis develops, regular ultrasound surveillance for liver cancer becomes standard, per major liver-society guidance.
Prognosis and Relapse Risk
Patients who reach and maintain biochemical remission generally have long-term survival approaching that of the general population. Cirrhosis at diagnosis worsens the outlook but does not eliminate the chance of remission. A large share of patients relapse within a few years of stopping treatment, which is why many hepatologists favor indefinite low-dose maintenance over repeated stop-and-start attempts. Regular follow-up and lab monitoring are central to catching relapse early.
Liver transplantation is reserved for acute (fulminant) liver failure or end-stage cirrhosis. Outcomes after transplant are generally good, though AIH can recur in the transplanted liver in a minority of patients, so monitoring continues afterward.
When to See a Doctor
Persistent fatigue paired with abnormal liver enzymes on routine labs warrants a workup, not reassurance. Anyone with a personal or family history of autoimmune disease who develops unexplained jaundice, right-upper-quadrant tenderness, or ongoing itching should request liver function tests and ask about further evaluation. A hepatologist or a gastroenterologist with liver expertise is the right specialist; primary care can run initial labs, but the diagnostic algorithm and long-term immunosuppression really need a subspecialist.
Frequently Asked Questions
Can autoimmune hepatitis go into remission without medication?
Spontaneous remission is uncommon and usually not durable. Untreated symptomatic AIH historically carried a high mortality, which is why modern guidance recommends treatment for nearly all symptomatic patients and most asymptomatic ones with significant inflammation on biopsy. Whether and how to treat is a decision for your specialist.
Is autoimmune hepatitis the same as fatty liver disease?
No. Metabolic (fatty) liver disease is driven largely by factors like excess weight and insulin resistance, while autoimmune hepatitis is immune-mediated. The two can coexist, which sometimes complicates interpretation of liver enzymes and biopsies.
Will I need a liver transplant?
Most patients diagnosed and treated early do not. The risk of eventually needing a transplant climbs in patients who delay treatment, repeatedly relapse, or were already cirrhotic at diagnosis. Early specialist care is the best way to lower that risk.
Can pregnancy worsen autoimmune hepatitis?
Disease activity often quiets during pregnancy and can flare afterward. Some immunosuppressants (such as azathioprine) are generally considered compatible with pregnancy under specialist supervision, while others (such as mycophenolate) are unsafe and must be stopped well before conception. Anyone with AIH who is pregnant or planning pregnancy should coordinate closely with both a hepatologist and an obstetric provider.
What should I avoid if I have autoimmune hepatitis?
Generally, alcohol; starting or stopping medicines (including over-the-counter drugs and supplements) without checking with your clinician; and, while immunosuppressed, live vaccines and high-risk raw foods. Your care team will tailor these to your situation.
The Bottom Line
Autoimmune hepatitis used to be a uniformly grim diagnosis. Today it is a chronic but highly treatable condition for the majority of patients who reach a hepatologist before significant fibrosis sets in. The hard part is recognizing it – vague fatigue and abnormal liver enzymes can sit unexplained for years. If your AST or ALT keeps coming back elevated, push for the autoantibody panel and IgG, and do not accept “your liver enzymes are a little high” as a final answer. Then let a specialist, not the internet, direct your treatment.
Medical disclaimer: This article is for general education only and is not medical advice, and it intentionally does not provide a dosing or tapering schedule. Autoimmune hepatitis is diagnosed and managed by a hepatologist or liver-focused gastroenterologist, and its medications – corticosteroids and immunosuppressants – must be prescribed, dosed, and monitored by a licensed clinician. Do not start, stop, increase, or taper these medicines on your own; abrupt changes can be dangerous. Follow your prescriber’s instructions and your pharmacy label. In an emergency (confusion with jaundice, vomiting blood, black stools), call 911 or go to the nearest ER; for a suspected medication overdose, call Poison Control at 1-800-222-1222.
Sources
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – Autoimmune Hepatitis (niddk.nih.gov)
- MedlinePlus – Autoimmune Hepatitis (medlineplus.gov)
- American Association for the Study of Liver Diseases (AASLD) – AIH practice guidance (aasld.org) – verify current version
- Mayo Clinic – Autoimmune hepatitis (symptoms, causes, and management)